L01F Monoclonal antibodies and antibody drug conjugates Monoclonal antibodies and antibody drug conjugates Monoclonal antibodies and antibody drug conjugates Monoclonal antibodies and antibody drug conjugates L3
Source: Wikipedia · CC BY-SA 4.0 Fuente: Wikipedia · CC BY-SA 4.0 · nombre de respaldo (en) 来源:维基百科 · CC BY-SA 4.0 · 回退名 (en) 來源:維基百科 · CC BY-SA 4.0 · 回退名 (en)
ATC level L3 · Search this class · Consumer categories
Child classes
L01FACD20 (clusters of differentiation 20) inhibitors CD20 (clusters of differentiation 20) inhibitors CD20 (clusters of differentiation 20) inhibitors CD20 (clusters of differentiation 20) inhibitorsL01FBCD22 (clusters of differentiation 22) inhibitors CD22 (clusters of differentiation 22) inhibitors CD22 (clusters of differentiation 22) inhibitors CD22 (clusters of differentiation 22) inhibitorsL01FCCD38 (clusters of differentiation 38) inhibitors CD38 (clusters of differentiation 38) inhibitors CD38 (clusters of differentiation 38) inhibitors CD38 (clusters of differentiation 38) inhibitorsL01FDHER2 (human epidermal growth factor receptor 2) inhibitors HER2 (human epidermal growth factor receptor 2) inhibitors HER2 (human epidermal growth factor receptor 2) inhibitors HER2 (human epidermal growth factor receptor 2) inhibitorsL01FEEGFR (epidermal growth factor receptor) inhibitors EGFR (epidermal growth factor receptor) inhibitors EGFR (epidermal growth factor receptor) inhibitors EGFR (epidermal growth factor receptor) inhibitorsL01FFPD-1/PDL-1 (programmed cell death protein 1/ death ligand 1) inhibitors PD-1/PDL-1 (programmed cell death protein 1/ death ligand 1) inhibitors PD-1/PDL-1 (programmed cell death protein 1/ death ligand 1) inhibitors PD-1/PDL-1 (programmed cell death protein 1/ death ligand 1) inhibitorsL01FGVEGF/VEGFR (vascular endothelial growth factor) inhibitors VEGF/VEGFR (vascular endothelial growth factor) inhibitors VEGF/VEGFR (vascular endothelial growth factor) inhibitors VEGF/VEGFR (vascular endothelial growth factor) inhibitorsL01FXOther monoclonal antibodies and antibody drug conjugates Other monoclonal antibodies and antibody drug conjugates Other monoclonal antibodies and antibody drug conjugates Other monoclonal antibodies and antibody drug conjugates
Active ingredients in this class
95 active ingredients 95 principios activos 95 个活性成分 95 個有效成分
Each market now shows one aggregated status: a market counts as on sale if it has any active record; individual record statuses are shown in the details. The same market can also have several registration records with different statuses, so each market appears only once here; that is a record fact, not a safety judgement.
A missing name is marked in its row only when it is the exception; when most names lack it, the list stays unmarked.
- Trastuzumab
L01FD01active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG CN ES MX TW EU · unknown HK - Bevacizumab
L01FG01active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG CN ES MX TW EU · unknown HK - Rituximab
L01FA01active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG CN ES MX TW EU · unknown HK - Nivolumab
L01FF01active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG CN ES MX TW EU · unknown HK - Pertuzumab
L01FD02active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG CN ES MX TW EU · unknown HK - Pembrolizumab
L01FF02active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG CN ES MX TW EU · unknown HK - Atezolizumab
L01FF05active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG CN ES MX TW EU · unknown HK - Amivantamab
L01FX18active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG CN ES MX TW EU · unknown HK - Cetuximab
L01FE01active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG CN ES TW EU · unknown MX HK - Inotuzumab Ozogamicin
L01FB01active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG CN ES MX TW EU · unknown HK - Trastuzumab Emtansine
L01FD03active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG ES TW EU · unknown MX HK - Ipilimumab
L01FX04active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG ES MX TW EU · unknown HK - Durvalumab
L01FF03active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG ES TW EU · discontinued MX · unknown HK - Enfortumab Vedotin
L01FX13active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG ES MX TW EU · unknown HK - Epcoritamab
L01FX27active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG ES MX TW EU · unknown HK - Ramucirumab
L01FG02active US GB CA SG CN · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA SG CN ES TW EU · discontinued MX · unknown HK - Panitumumab
L01FE02active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG ES TW EU · discontinued MX · unknown HK - Tremelimumab
L01FX20active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG ES MX TW EU · unknown HK - Tislelizumab
L01FF09active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG CN ES TW EU · unknown HK - Obinutuzumab
L01FA03active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG CN ES TW EU · unknown HK - Avelumab
L01FF04active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG ES TW EU · discontinued MX · unknown HK - Trastuzumab Deruxtecan
L01FD04active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG ES MX TW EU · unknown HK - Dostarlimab
L01FF07active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG ES MX TW EU · unknown HK - Sacituzumab Govitecan
L01FX17active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG ES MX TW EU · unknown HK - Daratumumab
L01FC01active US GB CA AU SG · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA AU SG ES TW EU · unknown HK - Isatuximab
L01FC02active US GB CA SG ES · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA SG ES TW EU · unknown AU HK - Elranatamab
L01FX32active US GB CA AU SG · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA AU SG ES TW EU · unknown HK - Polatuzumab Vedotin
L01FX14active US GB CA SG ES · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA SG ES TW EU · unknown AU HK - Glofitamab
L01FX28active US GB CA AU SG · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA AU SG ES TW EU · unknown HK - Talquetamab
L01FX29active US GB CA SG ES · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA SG ES TW EU · unknown AU HK - Teclistamab
L01FX24active US GB CA SG ES · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA SG ES TW EU · unknown AU HK - Zolbetuximab
L01FX31active US GB CA SG TW · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA SG TW EU · discontinued ES · unknown AU HK - Toripalimab
L01FF13active US GB CA AU SG · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA AU SG CN ES EU · unknown HK - Brentuximab Vedotin
L01FX05active US GB CA AU SG · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA AU SG ES TW EU · unknown HK - Gemtuzumab Ozogamicin
L01FX02active US GB CA AU SG · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA AU SG ES TW EU · unknown HK - Loncastuximab Tesirine
L01FX22active US GB CA SG TW · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA SG TW EU · discontinued ES · unknown AU HK - Mosunetuzumab
L01FX25active US GB CA SG ES · and 4 more y 4 más 另有 4 个 另有 4 個
active US GB CA SG ES TW EU · unknown HK - Belantamab Mafodotin
L01FX15active US GB CA ES TW · and 4 more y 4 más 另有 4 个 另有 4 個
active US GB CA ES TW EU · unknown AU HK - Elotuzumab
L01FX08active US GB AU ES TW · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB AU ES TW EU · discontinued CA · unknown HK - Tarlatamab
L01FX33active GB CA SG TW EU · and 5 more y 5 más 另有 5 个 另有 5 個
active GB CA SG TW EU · discontinued ES · unknown AU HK - Cemiplimab
L01FF06active US GB CA AU ES · and 3 more y 3 más 另有 3 个 另有 3 個
active US GB CA AU ES MX TW EU - Tafasitamab
L01FX12active US GB CA AU ES · and 4 more y 4 más 另有 4 个 另有 4 個
active US GB CA AU ES TW EU · unknown HK - Blinatumomab
L01FX07active GB CA AU SG ES · and 4 more y 4 más 另有 4 个 另有 4 個
active GB CA AU SG ES TW EU · unknown HK - Mogamulizumab
L01FX09active US GB CA AU SG · and 3 more y 3 más 另有 3 个 另有 3 個
active US GB CA AU SG ES TW EU - Mirvetuximab Soravtansine
L01FX26active US GB CA SG ES · and 4 more y 4 más 另有 4 个 另有 4 個
active US GB CA SG ES TW EU · unknown AU - Datopotamab Deruxtecan
L01FX35active US SG MX TW EU · and 5 more y 5 más 另有 5 个 另有 5 個
active US SG MX TW EU · discontinued ES · unknown AU HK - Dinutuximab Beta
L01FX06active GB ES TW EU · and 3 more y 3 más 另有 3 个 另有 3 個
active GB ES TW EU · unknown AU HK - Necitumumab
L01FE03active GB · and 7 more y 7 más 另有 7 个 另有 7 個
active GB · discontinued CA MX · withdrawn ES · unknown EU - Serplulimab
L01FF12active GB SG ES EU · and 2 more y 2 más 另有 2 个 另有 2 個
active GB SG ES EU · unknown HK - Tisotumab Vedotin
L01FX23active US GB EU · and 4 more y 4 más 另有 4 个 另有 4 個
active US GB EU · discontinued ES · unknown HK - Zanidatamab
L01FD07active US GB CA EU · and 2 more y 2 más 另有 2 个 另有 2 個
active US GB CA EU · discontinued ES - Catumaxomab
L01FX03active GB EU · and 3 more y 3 más 另有 3 个 另有 3 個
active GB EU · discontinued CA ES - Retifanlimab
L01FF10active US CA EU · and 2 more y 2 más 另有 2 个 另有 2 個
active US CA EU · discontinued ES - Olaratumab
L01FX10active GB · and 4 more y 4 más 另有 4 个 另有 4 個
active GB · discontinued CA · withdrawn EU - Linvoseltamab
L01FXactive US EU · and 2 more y 2 más 另有 2 个 另有 2 個
active US EU · discontinued ES - Dinutuximab
L01FX06active US CA · and 2 more y 2 más 另有 2 个 另有 2 個
active US CA · withdrawn EU - Sugemalimab
L01FF11active MX EU · and 2 more y 2 más 另有 2 个 另有 2 個
active MX EU · discontinued ES - Odronextamab
L01FX34active EU · and 2 more y 2 más 另有 2 个 另有 2 個
active EU · discontinued ES - Naxitamab
L01FX21active US · and 2 more y 2 más 另有 2 个 另有 2 個
active US · unknown HK - 罗普司亭N01
L01FESalt form: 西妥昔单抗N01
西妥昔单抗N01active CN
active CN - 达雷妥尤单抗
L01FCactive CN
active CN - 瑞帕妥单抗
L01FAactive CN
active CN - 贝莫苏拜单抗
L01FFactive CN
active CN - 塔奎妥单抗
L01FXactive CN
active CN - 维恩妥尤单抗
L01FXactive CN
active CN - 莫妥珠单抗
L01FXactive CN
active CN - 埃纳妥单抗
L01FXactive CN
active CN - 特立妥单抗
L01FXactive CN
active CN - 伊尼妥单抗
L01FDactive CN
active CN - 艾沙妥昔单抗
L01FCactive CN
active CN - Margetuximab
L01FD06active US
active US - 恩朗苏拜单抗
L01FFactive CN
active CN - 索卡佐利单抗
L01FFactive CN
active CN - 卡瑞利珠单抗
L01FFactive CN
active CN - 佐妥昔单抗
L01FXactive CN
active CN - 普特利单抗
L01FFactive CN
active CN - 那西妥单抗
L01FXactive CN
active CN - 泽贝妥单抗
L01FAactive CN
active CN - 戈沙妥珠单抗
L01FXactive CN
active CN - 维泊妥珠单抗
L01FXactive CN
active CN
Show all 95 (currently showing 80) Mostrar los 95 (ahora se muestran 80) 显示全部 95 个(当前显示前 80 个) 顯示全部 95 個(目前顯示前 80 個)
- 阿得贝利单抗
L01FFactive CN
active CN - 依沃西单抗
L01FXactive CN
active CN - 德曲妥珠单抗
L01FDactive CN
active CN - 艾帕洛利托沃瑞利单抗
L01FFactive CN
active CN - 斯鲁利单抗
L01FFactive CN
active CN - 索米妥昔单抗
L01FXactive CN
active CN - 舒格利单抗
L01FFactive CN
active CN - 格菲妥单抗
L01FAactive CN
active CN - 莫格利珠单抗
L01FXactive CN
active CN - 菲诺利单抗
L01FFactive CN
active CN - 卡度尼利单抗
L01FFactive CN
active CN - 芦康沙妥珠单抗
L01FXactive CN
active CN - 塔戈利单抗
L01FFactive CN
active CN - 信迪利单抗
L01FFactive CN
active CN - 西妥昔单抗β
L01FEactive CN
active CN
Class names are editorial translations or come from Wikipedia (CC BY-SA 4.0) / Wikidata (CC0); each ATC page lists the exact source, licence and link for every language. Only the ATC code and the WHO hierarchy are authoritative.
Notes & licences
Status badges summarise the product records held for each ingredient (active / discontinued / withdrawn / unknown), and the market codes after each badge show where that status is recorded. Only some registers publish a status column: CA, ES and MX do; AU and HK have no status column and are recorded as unknown; CN, US, GB, TW and SG records are on the register and marked active.
Class and category names are editorial or AI-assisted translations; only the ATC code and the WHO hierarchy are authoritative.
ATC codes and hierarchy reference the WHO Collaborating Centre for Drug Statistics Methodology ATC/DDD Index (copyright WHOCC; the index itself is not reproduced). Ingredient/strength facts come from the regulator records listed on About.